Natural History of HPV Infection in Men: The HIM Study
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Infectious Disease, Women's Studies |
| Therapuetic Areas: | Immunology / Infectious Diseases, Reproductive |
| Healthy: | No |
| Age Range: | 18 - 70 |
| Updated: | 3/3/2019 |
| Start Date: | June 14, 2005 |
| End Date: | May 2020 |
The purpose of this study is to learn about the natural history of Human Papillomavirus (HPV)
infection in men. The study will also find out what factors are linked to HPV in men
including other sexually transmitted diseases (STDs). If participants test positive for
syphilis, gonorrhea or chlamydia, we are required by law to report the results to the Florida
Department of Health. Participants will be able to get free medical treatment from the
Florida Department of Health for these STDs. Participants will be given a written report of
the results of the STD testing.
infection in men. The study will also find out what factors are linked to HPV in men
including other sexually transmitted diseases (STDs). If participants test positive for
syphilis, gonorrhea or chlamydia, we are required by law to report the results to the Florida
Department of Health. Participants will be able to get free medical treatment from the
Florida Department of Health for these STDs. Participants will be given a written report of
the results of the STD testing.
The study protocol will include a pre-enrollment run-in visit, a baseline visit (enrollment),
and 8 additional visits after enrollment scheduled 6 months apart. Intervals of every 6
months were chosen to insure that both acquisition and loss of infections may be assessed, as
studies in women indicate that median duration of oncogenic infections ranges between 7-9
months. Informed consent will occur during the run-in visit. The run-in and follow-up visits
will include questionnaire administration, visual inspection of the skin and external
genitalia, and the collection of urine, blood, oral cells, and penile skin samples If
anogenital lesions are present at any of the clinic visits, they will be sampled as well.
and 8 additional visits after enrollment scheduled 6 months apart. Intervals of every 6
months were chosen to insure that both acquisition and loss of infections may be assessed, as
studies in women indicate that median duration of oncogenic infections ranges between 7-9
months. Informed consent will occur during the run-in visit. The run-in and follow-up visits
will include questionnaire administration, visual inspection of the skin and external
genitalia, and the collection of urine, blood, oral cells, and penile skin samples If
anogenital lesions are present at any of the clinic visits, they will be sampled as well.
Inclusion Criteria:
- Men between 18 and 70 years of age, living in Southern Florida, US; Sao Paulo, Brazil;
or state of Morelos, Mexico.
- Participant has never been told that they have penile or anal cancer or genital warts.
- Willing to attend scheduled visits every 6 months in the next 4 years.
Exclusion Criteria:
- Prospective participants with symptoms of any STD (excluding HPV) during screening
will not be eligible to participate in the study until the STD (Sexually Transmitted
Disease) infection is gone.
We found this trial at
1
site
12902 USF Magnolia Dr
Tampa, Florida 33612
Tampa, Florida 33612
(888) 663-3488
H. Lee Moffitt Cancer Center & Research Institute Moffitt Cancer Center in Tampa, Florida, has...
Click here to add this to my saved trials
